Haim Zaltzman

Haim’s representative transactions include advising/representing on these recent transactions:

Technology Debt

• Hercules Capital in tens of structured and venture debt facilities, including multiple recurring revenue facilities.
• Sixth Street, a leading global investment firm, on the growth financing for Bourque Logistics, a provider of rail logistics systems
• DailyPay, a leading fintech company, in securing US$100 million to its secured credit facility capacity from Citi for a total of almost US$1 billion in capacity
• Wolfspeed on: 
  • Funding agreements worth US$750 million with the US Department of Commerce under the CHIPS Act and a consortium of strategic investment funds
  • A bespoke unsecured customer deposit facility, valued at up to US$2 billion, with an affiliate of Renesas Electronics Inc., in connection with a long-term supply agreement
  • A US$2 billion senior secured note financing with a group of private investors led by Apollo Global Management
• Thumbtack in a US$75 million financing from Hercules Capital, Inc. and Silicon Valley Bank
• Blue Owl, a leading tech investor, in TravelPerk’s credit facility of up to US$135 million, together with Blackstone
• Francisco Partners in the US$90 million term loan to Property Finder, which constituted one of the largest growth financings in the Middle East
• Monroe Capital as sole lead arranger and administrative agent on the funding of a senior credit facility to support the merger and future growth of ParkHub and JustPark by LLR Partners and FTV Capital
• VideoAmp, Inc., a leading media-focused software company, in an equity investment from Vista Credit Partners for up to US$150 million of VideoAmp’s Series G preferred stock
• Vox Media, the leading modern media company, in a revolving credit facility issued by Silicon Valley Bank
• Yield Engineering Systems, a leading provider of semiconductor process equipment and material solutions technology, in a US$55 million IP-backed financing from a fund managed by Aon Advantage Funds LLC
• Lyft, Inc. on a senior secured revolving credit facility worth US$420 million
• Sixth Street, Golub Capital LLC, and other lenders on CommerceHub’s acquisition of outstanding shares of ChannelAdvisor
• Carlyle Global Credit on the financing in support of Turn/River Capital’s take-private acquisition of Tufin
• Cipher Mining on its joint venture affiliate Alborz’s two-year US$46.9 million secured credit facility with BlockFi Lending LLC

Technology Corporate

• Hercules Capital in tens of growth facilities for leading technology companies in and outside of the US, including in the US$100 million debt financing for Pindrop, and the US$125 million growth financing for Semperis
• Blue Owl Capital in its US$401 million structured capital financing for Arctic Wolf
• Maverick Capital: 
  • As investment adviser in TensorWave’s up to US$43 million funding round
  • In a US$70 million funding round for AI-driven semiconductor technology leader SiMa.ai
• Blue Owl, a leading tech investor, in: 
  • The transaction for CloudPay’s US$120 million financing round
  • TravelPerk’s credit facility of up to US$135 million, together with Blackstone
• Morgan Stanley Tactical Value in: 
  • A US$100 million growth investment for Clip, Mexico’s leading digital payments and commerce platform, which was one of the largest growth fundings in Latin America
  • An oversubscribed late-stage convertible investment round of US$401 million for Netskope, a leader in cloud computing security and networking
• Cheq Lifestyle Technology in its acquisition by Cantaloupe
• Sixth Street Growth on its investment in a €285 million funding round for SumUp, a leading global financial services company
• VideoAmp, Inc., a leading media-focused software company, in an equity investment from Vista Credit Partners for up to US$150 million of VideoAmp’s Series G preferred stock
• Ouster, a leading provider of high-resolution digital lidar, in its merger-of-equals with Velodyne, a leading global player in lidar sensors and solutions
• Francisco Partners on US$75 million of committed financing related to Movella’s and Pathfinder Acquisition Corporation’s business combination
• ParaFi Capital as lead investor in ConsenSys’ US$450 million Series D funding

Life Sciences Debt

• Ascendis Pharma in a US$150 million royalty funding agreement with Royalty Pharma
• Arcus Biosciences in a US$250 million term loan facility from Hercules Capital
• scPharmaceuticals on a senior secured term loan and a royalty investment from funds managed by Perceptive Advisors
• Health Catalyst, the leading provider of healthcare data technology, in a US$225 million credit facility provided by Silver Point Finance
• SLR Capital on debt restructuring, structured equity investment, and corporate matters related to the Vapotherm merger and take-private
• Verona Pharma in strategic financing agreements worth US$650 million from funds managed by Oaktree Capital Management and OMERS Life Sciences
• Hercules Capital on providing senior secured acquisition financing for the merger between Everside Health and Marathon Health
• BridgeBio Pharma in a US$1.25 billion strategic investment (combination senior secured debt and royalty investment) from Blue Owl Capital and Canada Pension Plan Investment Board
• Nevro Corp., a global medical device company, in its acquisition of Vyrsa Technologies and related US$200 million term loan
• Ascendis Pharma in its US$150 million royalty funding agreement with Royalty Pharma
• Oaktree Capital Management in a US$100 million secured credit financing agreement for Harrow, a leading US eyecare pharmaceutical company
• Alignment Healthcare, a leading tech-enabled MedicareAdvantage company, on a US$250 million senior secured term loan facility with Oxford Finance LLC
• Rhythm Pharmaceuticals, Inc. on a revenue interest financing agreement with HealthCare Royalty Partners worth US$100 million

Life Sciences Corporate

• SLR Capital Partners in corporate matters related to Vapotherm’s merger with a newly formed entity organized and funded by an affiliate of Perceptive Advisors
• Ascendis Pharma in a US$150 million royalty funding agreement with Royalty Pharma
• scPharmaceuticals on a senior secured term loan and a royalty investment from funds managed by Perceptive Advisors
• Verona Pharma in strategic financing agreements worth US$650 million from funds managed by Oaktree Capital Management and OMERS Life Sciences
• BridgeBio Pharma in a US$1.25 billion strategic investment (combination senior secured debt and royalty investment) from Blue Owl Capital and Canada Pension Plan Investment Board
• Bolt Threads in its business combination with Golden Arrow Merger Corp., involving a concurrent financing, PIPE, and SPAC deal
• Ascendis Pharma in its US$150 million capped synthetic royalty funding agreement with Royalty Pharma
• Rhythm Pharmaceuticals, Inc. on a revenue interest financing agreement with HealthCare Royalty Partners worth US$100 million